Blog

SPOT-MAS NEWS

Current cancer screening methods are predominantly organ specific, utilizing diagnostic imaging tests with multiple modalities.
Current cancer screening methods are predominantly organ specific, utilizing diagnostic imaging tests with multiple modalities.
Cell free DNA (cfDNA)-based assays hold great potential in detecting early cancer signals. However, predicting the tissue-of-origin for multiple cancer types at an early stage remains challenging due to the low abundance of tumor- derived cfDNA and the confounding presence of various DNA components released from non- tumor sources.

Gene Solutions News

SPOT-MAS video